BANK OF AMERICA CORP /DE/
BankPosition in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 70858
CHARLOTTE, NC
Position in MRVI
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,647,656
-$632,914 QoQ
Shares Held
582,211
-17.0% QoQ
Ownership
0.225%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99.77413686790528.ToString("F0")%
Shared 0.ToString("F0")%
None 0.22586313209472167.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,554,846,017 across 346 Biotechnology names. MRVI ranks #195 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in MRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,647,656 | 582,211 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,280,570 | 701,714 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,110,883 | 1,432,364 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $2,481,443 | 1,029,645 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,941,351 | 878,440 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,756,039 | 689,182 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,433,077 | 894,474 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $7,403,679 | 1,034,034 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $11,219,046 | 1,294,008 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,539,001 | 540,306 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $11,943,930 | 1,194,393 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $14,134,099 | 1,137,096 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,543,914 | 467,089 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,570,861 | 179,655 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,643,092 | 103,529 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,063,571 | 213,431 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $14,198,958 | 402,579 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $18,626,725 | 444,552 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $23,067,942 | 470,007 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,161,520 | 435,215 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $2,157,217 | 60,528 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,620,233 | 93,413 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||